Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06610162 · ClinicalTrials.gov registry record · NA

Thermogenenic Responses to Fasting and Overfeeding in Women

A NA study of Obesity, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT06610162: Recruiting NA study of Obesity, sponsored by University of Colorado, Denver.

NCT06610162 is a NA study of Obesity that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 56 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06610162, a NA study of Obesity, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The weight gained is primarily body fat, particularly visceral or abdominal body fat. The excess gain in abdominal fat during menopause increases the risk of chronic metabolic diseases such as heart disease and diabetes. The increase in weight and body fat with menopause may be due to changes in metabolism related to the loss of estrogen. This study plans to compare how the metabolism of premenopausal and postmenopausal women responds to changes in energy intake. The investigators will compare the changes in energy expenditure that occur during a period of acute fasting (24 hours) and a period of consuming excess calories (overfeeding).

Primary Outcome

The number of calories burned over a set period of time

Conditions Studied

Interventions

  • OTHER Eucalaloric feeding
  • OTHER Acute Fasting
  • OTHER Acute Overfeeding

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2025-01-01
Est. Completion 2030-12-31
Phase NA
University of Colorado, Denver

1,283 total trials

What NCT06610162 shows while recruiting

NCT06610162 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Eucalaloric feeding is the first listed.

NCT06610162 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT06610162 about?

NCT06610162 is a clinical study titled "Thermogenenic Responses to Fasting and Overfeeding in Women". This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The weight gained is primarily body fat, particularly visceral or abdominal body fat. The excess gain in abdominal fat during menopause increase...

What is the current status of trial NCT06610162?

This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2025-01-01. Estimated completion is 2030-12-31.

What conditions does trial NCT06610162 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT06610162?

The interventions under investigation include: Eucalaloric feeding (OTHER), Acute Fasting (OTHER), Acute Overfeeding (OTHER).

Who is sponsoring clinical trial NCT06610162?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06610162 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06610162's enrollment target sits among peer trials

56 689th of 1053 higher than 360 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06610162, the US trial registry maintained by the National Library of Medicine. NCT06610162 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.